Explore the vast range of titles available.

In the last few years, nutritional and lifestyle psychiatry has emerged as a novel scientific topic, highlighting the impact of nutrition and lifestyle in the onset, prevention and management of diverse mental diseases [...]

PurposeTo evaluate the Mediterranean diet (MD) adherence of an elderly Greek population, and its association with the grade of cognitive decline and psychological status.MethodsMini-Mental State Examination (MMSE), Geriatric Depression Scale (GDS), and Mediterranean diet score (MedDietScore) questionnaires were used to assess the impact of MD adherence on cognitive abilities and psychological state of a Greek elderly population.Participants2092 men and women over 65 years old (mean age 74.97 ± 8.41 years) from seven different Greek citiesResults34.4% of the study population showed cognitive impairment, while 32.3% of the participants had depressive symptoms. More than half of the participants (52.1%) showed very low or low MD adherence. Higher MD adherence was significantly associated with better MMSE and GDS scores. Moreover, higher MD adherence was significantly associated with younger age, female gender, higher educational level, and better anthropometric parameters. MD adherence was independently associated with cognitive and psychological status, and gender after adjustment for potential confounders.ConclusionHigher MD adherence is strongly associated with better cognitive status and less depressive symptomatology. Public health policies are recommended to focus on the promotion of the MD, as a crucial strategy to reduce the risk of cognitive impairment and depression.

This paper contains a revision of the Harris–Benedict equations through the development and validation of new equations for the estimation of resting metabolic rate (RMR) in normal, overweight, and obese adult subjects, taking into account the same anthropometric parameters. A total of 722 adult Caucasian subjects were enrolled in this analysis. After taking a detailed medical history, the study enrolled non-hospitalized subjects with medically and nutritionally controlled diseases such as diabetes mellitus, cardiovascular disease, and thyroid disease, excluding subjects with active infections and pregnant or lactating women. Measurement of somatometric characteristics and indirect calorimetry were performed. The values obtained from RMR measurement were compared with the values of the new equations and the Harris–Benedict, Mifflin–St Jeor, FAO/WHO/UNU, and Owen equations. New predictive RMR equations were developed using age, body weight, height, and sex parameters. RMR males: (9.65 × weight in kg) + (573 × height in m) − (5.08 × age in years) + 260; RMR females: (7.38 × weight in kg) + (607 × height in m) − (2.31 × age in years) + 43; RMR males: (4.38 × weight in pounds) + (14.55 × height in inches) − (5.08 × age in years) + 260; RMR females: (3.35 × weight in pounds) + (15.42 × height in inches) − (2.31 × age in years) + 43. The accuracy of the new equations was tested in the test group in both groups, in accordance with the resting metabolic rate measurements. The new equations showed more accurate results than the other equations, with the equation for men (R-squared: 0.95) showing better prediction than the equation for women (R-squared: 0.86). The new equations showed good accuracy at both group and individual levels, and better reliability compared to other equations using the same anthropometric variables as predictors of RMR. The new equations were created under modern obesogenic conditions, and do not exclude individuals with regulated (dietary or pharmacological) Westernized diseases (e.g., cardiovascular disease, diabetes, and thyroid disease).

For many years, herbs and spices have been used, due to their aroma and flavor, in the food industry and cuisine. It is also well known that phytochemicals from these plant parts have many health benefits and are used for the prevention and treatment of many human diseases. Basil (with the most representative species ) is a perennial herb with a characteristic aroma, containing many bioactive components such as phenolic acids, flavonoids, tannins, saponins, alkaloids, polysaccharides, vitamins, proteins, amino acids, and essential oils, with beneficial effects on human health. The aim of this study is to review the antioxidant, antimicrobial, and anticancer activity of basil, according to recent literature. A thorough search in the international databases (Scopus, PubMed, Google Scholar, and Web of Sciences) was conducted from January 2015 to October 2025, using characteristic keywords in combinations. Bioactive components of basil show a significant antioxidant activity, as detected by radical scavenging activity (measured by the 2,2-diphenyl-1-picrylhydrazyl (DPPH), 2,2'-azino-bis-(3-ethylbenzothiazoline-6-sulfonic acid (ABTS), ferric reducing antioxidant power (FRAP), oxygen radical absorbance capacity (ORAC) assays), activation of antioxidant enzymes (glutathione peroxidase (GPX), superoxide dismutase (SOD), catalase (CAT)), enhancement of reduced glutathione (GSH) and reduction in malondialdehyde (MDA) and thiobarbituric acid-reactive substance (TBARS) levels, and protection of cells from hydrogen peroxide (H O )-toxicity. Additionally, inhibition of growth and cell death of many Gram-positive and Gram-negative bacteria strains, maintained by cell membrane damage, inhibition of efflux pumps, as well as inhibition of biofilm formation, anti-protozoan, antifungal, and antiviral activities, have been noticed for basil bioactive components. A synergism with antibiotics has also been reported. Finally, anticancer activity has been reported, according to apoptosis induction, cell cycle arrest, anxiety reduction, and health improvement of cancer patients. Basil bioactive components have been reported for their high antioxidant, antimicrobial, and anticancer properties. However, future studies, especially at the clinical level, are strongly proposed in order to unravel the significant role of basil in human health and the safety of its bioactive components in healthcare usage.

Background: Swimming coaches search for the most efficient training approach and stimuli for swimmers’ improvement. High-intensity interval training (HIIT) is a well-established training approach used by coaches to accelerate swimmers’ improvement. A HIIT variation, which has lately been discussed by many coaches about its possible effectiveness on performance, is Ultra Short Race Pace Training (USRPT). The present case study aimed to examine the effect of a faster-than-race pace test set (FRPtS) on the performance of a middle-distance (MD) swimmer at the freestyle events. Methods: This case study included a 21-year-old national-level MD swimmer with 16 years of swimming experience. The swimmer followed 11 weeks of FRPtS sets in a 17-week training intervention. The FRPtS sets were repeated two to three times per week, the volume ranged from 200 m to 1200 m, and the distances that were used were 25 m, 50 m, and 100 m at a faster pace than the 400 m. Descriptive statistics were implemented, recording the average with standard deviation (number in parentheses), the sum, and the percentages (%). Results: According to the results, the swimmer improved his personal best (PB) and season best (SB) performance in the events of 200 m and 400 m freestyle. Specifically, the improvement from his PB performance was 2.9% (−3.49 s) and 1.0% (−2.55 s), whereas in his SB performance it was 2.9% (−3.53 s) and 4.4% (−11.43 s) for the 200 and 400 m freestyle, respectively. Conclusions: Concluding, FRPtS is assumed to have beneficial effects on the swimming performance of MD events. However, further crossover or parallel studies on different swimming events with more participants and biomarkers must be conducted to clarify the effects of that kind of training on swimming performance.

Osteoporosis is a common disease, defined primarily by a low measured bone density, which is associated with an increased risk of fragility fractures. Low calcium intake and vitamin D deficiency seem to be positively correlated with the prevalence of osteoporosis. Although they are not suitable for the diagnosis of osteoporosis, the biochemical markers of bone turnover can be measured in serum and/or urine, enabling the assessment of the dynamic bone activity and the short-term effectiveness of the osteoporosis treatment. Calcium and vitamin D are essential for maintaining bone health. The aim of this narrative review is to summarize the effects of vitamin D and calcium supplementation separately and in combination, on bone density and circulating serum and blood plasma vitamin D, calcium, parathyroid hormone levels, markers of bone metabolism concentrations, and clinical outcomes, such as falls and osteoporotic fractures. We searched the PubMed online database to find clinical trials from the last five years (2016–April 2022). A total of 26 randomized clinical trials (RCTs) were included in this review. The present reviewed evidence suggests that vitamin D alone or in combination with calcium increases circulating 25(OH)D. Calcium with concomitant vitamin D supplementation, but not vitamin D alone, leads to an increase in BMD. In addition, most studies did not detect significant changes in circulating levels of plasma bone metabolism markers, nor in the incidence of falls. Instead, there was a decrease in blood serum PTH levels in the groups receiving vitamin D and/or Ca supplementation. The plasma vitamin D levels at the beginning of the intervention, and the dosing regimen followed, may play a role in the observed parameters. However, further study is needed to determine an appropriate dosing regimen for the treatment of osteoporosis and the role of bone metabolism markers.

Hu-antigen R (HuR) is an RNA-binding protein that regulates the stability, translation, and nucleus-to-cytoplasm translocation of target mRNAs. The aim of the present review was to summarize and present the currently available information in the English literature on HuR expression in various human tumors, verifying its possible clinical significance. HuR function is directly linked to its subcellular localization. In normal cells, HuR is mostly localized in the nucleus, while in malignant cells, an increase in cytoplasmic HuR levels has been noted, in both cell lines and tissue samples. Moreover, in malignancy, elevated HuR expression levels and cytoplasmic immunohistochemical pattern have been correlated with advanced clinicopathological parameters and altered expression levels of proteins implicated in neoplasia. Additionally, elevated HuR expression levels and mainly cytoplasmic immunohistochemical pattern were correlated with decreased patients’ survival rate in various human tumors. HuR is a putative drug target for cancer therapy, since it is expressed ubiquitously in malignant clinical samples and has an apparently consistent role in tumor formation and progression.

Background/Objectives: Emotional eating has been recognized as the tendency to eat in response to emotions, being recognized as a crucial risk factor for recurrent weight gain. Emotional eating has been interrelated with obesity/overweight, depression, anxiety, stress, and specific dietary habits at any stage of human life, negatively affecting human quality of life. The present study aims to summarize and explore the effects of emotional eating on children and how these effects may, in turn, influence their mental and physical health at the next stages of their lives. Methods: This is a narrative review of the presently existing clinical evidence concerning the impact of emotional eating in children. A comprehensive search of the most reliable online databases, e.g., PubMed, Scopus, Web of Science, and Google Scholar, was performed utilizing relevant keywords. Several inclusion and exclusion criteria were used to collect only cross-sectional, longitudinal, descriptive, and case–control surveys in children’s populations. Results: The current clinical evidence suggests that parental behavior may increase the risk of emotional eating in children. Several pieces of evidence also implied potential associations of emotional eating with overweight/obesity and mental disorders in children. Children’s dietary habits may also affect their risk of developing emotional eating. Conclusions: The prevalence of emotional eating is gradually increasing in the general population, and especially in children. Public strategies should be performed to educate parents to recognize potential emotional eating behaviors in their children and to adopt more healthy dietary habits for their children, even in the first months of their life. Educational programs should be organized in school communities to directly educate children on the benefits of healthy dietary patterns.

Wounds are disruptions of the dermal layer of the skin caused by physical, chemical, thermal, infectious, or immunological insults. Given the skin’s critical role in maintaining homeostasis and protecting against external threats, prompt and effective wound healing is essential to restore functionality and prevent further complications. Numerous natural products (NPs) have long been employed in wound care due to their antioxidant, anti-inflammatory, antimicrobial, and regenerative properties. Building on this historical and scientific foundation, the present literature review consolidates and critically evaluates recent experimental and clinical evidence on the wound healing potential of marigold (Calendula officinalis L.). By focusing on studies published between 2020 and 2025, this review captures the evolving understanding of the plant’s therapeutic applications, particularly in skin regeneration and wound management. For each selected publication, formulation type, intervention strategy, dosage, and key outcomes (such as healing rate, cell proliferation, and modulation of inflammatory markers) were summarized. This synthesis aims to provide an update on current evaluations involving C. officinalis and how this plant contributes to dermal repair and to identify promising directions for future research and clinical applications.

Background: Bipolar disorder is a chronic mental disease that is characterized by depressive and manic episodes. Antipsychotics and mood stabilizers are known therapies that work, but their restrictions and disadvantages resulted in the need for complementary and alternative therapies, such as natural compounds. Omega-3 fatty acids, as basic ingredients of fishes and seafood, play crucial roles in brain development, function of brain membrane enzymes, learning, and many other instances, and their deficiency has been associated with many mental diseases, including bipolar disorder. Methods: The present narrative review aims to critically summarize and scrutinize the available clinical studies on the use of omega-3 fatty acids in the management and co-treatment of bipolar disorder episodes and symptoms. For this purpose, a thorough and in-depth search was performed in the most accurate scientific databases, e.g., PubMed., Scopus, Web of Science, Cochrane, Embase, and Google Scholar, applying effective and relevant keywords. Results: There are currently several clinical studies that assessed the effect of omega-3 fatty acids on the severity of BD symptoms. Some of them supported evidence for the potential beneficial impact of omega-3 fatty acids supplementation in the prevention and/or co-treatment of bipolar disorder severity and symptomatology. Nevertheless, a considerable number of clinical studies did not show high efficiency, rendering the existing data rather conflicting. The above may be ascribed to the fact that there is a high heterogeneity amongst the available clinical studies concerning the dosage, the administration duration, the combination of fatty acids administration, the method designs and protocols, and the study populations. Conclusion: Although the currently available clinical evidence seems promising, it is highly recommended to accomplish larger, long-term, randomized, double-blind, controlled clinical trials with a prospective design in order to derive conclusive results as to whether omega-fatty acids could act as a co-treatment agent or even as protective factors against bipolar disorder symptomatology. Drug design strategies could be developed to derive novel synthetic omega-3 fatty acids analogs, which could be tested for their potential to attenuate the severity of BD episodes and symptoms.